BRIEF published on 07/29/2025 at 11:05, 8 months 15 days ago Meliodays and Celanese Collaborate on Hormone-Free IUD for Menstrual Pain Hormone-Free IUD Menstrual Pain Relief Meliodays VitalDose Platform Celanese Partnership
BRIEF published on 07/29/2025 at 11:05, 8 months 15 days ago Meliodays et Celanese collaborent sur un stérilet sans hormones pour les douleurs menstruelles Meliodays DIU Sans Hormones Soulagement Des Douleurs Menstruelles Plateforme VitalDose Partenariat Celanese
PRESS RELEASE published on 07/29/2025 at 11:00, 8 months 16 days ago Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain Meliodays Medical partners with Celanese to develop hormone-free non-contraceptive IUD for menstrual pain relief using VitalDose(R) Drug Delivery Platform Celanese Drug Delivery Menstrual Pain Meliodays Medical IUD
BRIEF published on 03/20/2025 at 09:10, 1 year ago Meliodays Medical Secures Over EUR 800,000 in Pre-Seed Financing Pre-seed Financing Menstrual Pain Meliodays Medical Local Treatment Innovative Healthcare
BRIEF published on 03/20/2025 at 09:10, 1 year ago Meliodays Medical obtient un financement de pré-amorçage de plus de 800 000 euros Financement De Pré-amorçage Meliodays Medical Douleurs Menstruelles Traitement Local Soins De Santé Innovants
PRESS RELEASE published on 03/20/2025 at 09:05, 1 year ago Meliodays Medical announces the closing of a pre-seed financing round of over EUR 800,000 Meliodays Medical announces successful closure of over EUR 800,000 pre-seed financing round led by capacura GmbH, focusing on new therapy for menstrual pain with hormone-free, local treatment Financing Hormone-free Menstrual Pain Meliodays Medical Pre-seed
Published on 04/14/2026 at 10:55, 7 minutes ago Waton Financial Marks One Year as a Listed Company with MOTA: A New Chapter in Human-AI Investment Collaboration
Published on 04/14/2026 at 09:05, 1 hour 57 minutes ago BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
Published on 04/14/2026 at 09:01, 2 hours 1 minute ago Star Copper Fully Funded 15,000 Metre Drill Program Targets Maiden Resource in 2026
Published on 04/13/2026 at 23:15, 11 hours 47 minutes ago Relevant Gold Completes Strategic Financing; Embarks on Largest Drilling Program in Company History
Published on 04/13/2026 at 23:00, 12 hours 2 minutes ago Sterling Metals Announces Sale Of Sail Pond Project
Published on 04/14/2026 at 10:30, 31 minutes ago Baucor Boosts European Operations with Strategic Product Expansion
Published on 04/14/2026 at 10:00, 1 hour 2 minutes ago ARTCLINE achieves milestone in septic shock: Patient recruitment for the ReActIF-ICE study successfully completed
Published on 04/14/2026 at 10:00, 1 hour 2 minutes ago Waton Financial Marks One Year as a Listed Company with MOTA: A New Chapter in Human-AI Investment Collaboration
Published on 04/14/2026 at 09:57, 1 hour 5 minutes ago Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
Published on 04/14/2026 at 09:43, 1 hour 18 minutes ago GFT named Leader in QKS Spark Matrix™ 2026 for Insurance Digital Transformation Services, Driving Faster, Lower-Risk Transformation
Published on 04/14/2026 at 08:30, 2 hours 32 minutes ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 15 hours 47 minutes ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 16 hours 47 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
Published on 04/13/2026 at 18:15, 16 hours 47 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026
Published on 04/13/2026 at 18:09, 16 hours 52 minutes ago Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.
